Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

8
Number of overlapping holdings
20.5%
% of GNOM's 40 holdings also in PBE
28.6%
% of PBE's 28 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in GNOM |
Weight in PBE |
Overlap | |
---|---|---|---|---|
NATERA INC | 6.3% | 4.7% | 4.7% | |
GILEAD SCIENCES INC | 3.3% | 5.1% | 3.3% | |
ILLUMINA INC | 2.9% | 4.3% | 2.9% | |
BIOMARIN PHARMACEUTICAL INC | 5.3% | 2.8% | 2.8% | |
BIO-TECHNE CORPORATION | 4.4% | 2.6% | 2.6% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to PBE
ALNYLAM PHARMACEUTICALS INC | 4.7% | |
AGILENT TECHNOLOGIES INC | 4.5% | |
BIONTECH SE SPONSORED ADR | 4.4% | |
GENSCRIPT BIOTECH CORPORATION | 4.2% | |
CRISPR THERAPEUTICS AG | 4.1% | |
LEGEND BIOTECH CORPORATION SPONSORED | 4.1% | |
BEAM THERAPEUTICS, INC. | 3.9% | |
AVIDITY BIOSCIENCES INC | 3.6% | |
ARROWHEAD PHARMACEUTICALS, INC. | 3.6% | |
ULTRAGENYX PHARMACEUTICAL IN | 3.6% |
GNOM Underweight Relative to PBE
NEUROCRINE BIOSCIENCES INC | -5.0% | |
AMGEN INC | -5.0% | |
BIOGEN IDEC INC | -5.0% | |
REGENERON PHARMACEUTICALS | -4.5% | |
UNITED THERAPEUTICS CORP | -4.4% | |
PROTAGONIST THERAPEUTICS, INC. | -3.9% | |
TG THERAPEUTICS INC | -3.8% | |
CATALYST PHARMACEUTICAL PART | -3.3% | |
HALOZYME THERAPEUTICS INC | -3.1% | |
PTC THERAPEUTICS INC | -3.0% |